| Literature DB >> 33231054 |
Guillermo Kohn-Loncarica1, Ana Fustiñana2, Franco Díaz-Rubio3, Juan C Jaramillo-Bustamante4, Sebastián González-Dambrauskas5, Pablo Vásquez-Hoyos6, Jaime Fernández-Sarmiento7, Gustavo González8, Alejandro Mansur9, Javier Ponce10, Roberto Jabornisky11.
Abstract
Multisystem inflammatory syndrome temporally related to COVID-19 in children and adolescents is a clinical presentation of SARS-CoV-2 infection. It shares some features with Kawasaki disease, toxic shock, sepsis, macrophage activation syndrome, and myocarditis. Few publications have addressed its initial management, which is similar to that proposed for septic shock. This review analyzes such approach based on the characteristics typical of multisystem inflammatory syndrome related to COVID-19 in accordance with the paradigm of an "institutional practice guideline" and suggests therapeutic approach strategies, including early detection, stabilization, referral, specific treatment, and process analysis. Sociedad Argentina de Pediatría.Entities:
Keywords: COVID-19; SARSCoV-2; multisystem inflammatory syndrome; patient care bundles; sepsis
Mesh:
Year: 2020 PMID: 33231054 DOI: 10.5546/aap.2020.eng.e514
Source DB: PubMed Journal: Arch Argent Pediatr ISSN: 0325-0075 Impact factor: 0.635